A detailed history of Graham Capital Management, L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 16,709 shares of BBIO stock, worth $411,375. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,709
Previous 387,100 95.68%
Holding current value
$411,375
Previous $12 Million 96.47%
% of portfolio
0.01%
Previous 0.34%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$23.0 - $31.04 $384,307 - $518,647
16,709 New
16,709 $423,000
Q4 2023

Feb 14, 2024

BUY
$24.02 - $43.89 $25,917 - $47,357
1,079 New
1,079 $43,000
Q3 2022

Nov 14, 2022

BUY
$7.94 - $12.36 $1.37 Million - $2.14 Million
172,855 Added 40.17%
603,126 $6 Million
Q2 2022

Aug 15, 2022

SELL
$5.21 - $12.14 $593,632 - $1.38 Million
-113,941 Reduced 20.94%
430,271 $3.91 Million
Q1 2022

May 16, 2022

BUY
$7.34 - $17.16 $3.99 Million - $9.34 Million
544,212 New
544,212 $5.52 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.65B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.